Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.80 0.00 (0.00%)
As of 03:48 PM Eastern

PETV vs. TELA, HYPR, NSPR, CTCX, SRTS, ZYXI, CTSO, RBOT, MDAI, and SURG

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include TELA Bio (TELA), Hyperfine (HYPR), InspireMD (NSPR), Carmell (CTCX), Sensus Healthcare (SRTS), Zynex (ZYXI), Cytosorbents (CTSO), Vicarious Surgical (RBOT), Spectral AI (MDAI), and SurgePays (SURG). These companies are all part of the "medical equipment" industry.

PetVivo vs. Its Competitors

TELA Bio (NASDAQ:TELA) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

TELA Bio has a net margin of -61.00% compared to PetVivo's net margin of -902.82%. TELA Bio's return on equity of -402.45% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-61.00% -402.45% -62.73%
PetVivo -902.82%-4,813.07%-281.78%

TELA Bio has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

PetVivo has lower revenue, but higher earnings than TELA Bio. PetVivo is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$69.30M1.10-$37.84M-$1.41-1.36
PetVivo$1.05M18.72-$10.95M-$0.42-1.90

TELA Bio currently has a consensus target price of $7.25, indicating a potential upside of 277.60%. Given TELA Bio's stronger consensus rating and higher probable upside, equities analysts plainly believe TELA Bio is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, TELA Bio had 4 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for TELA Bio and 1 mentions for PetVivo. TELA Bio's average media sentiment score of 0.69 beat PetVivo's score of 0.67 indicating that TELA Bio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TELA Bio
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PetVivo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

TELA Bio beats PetVivo on 12 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$19.58M$66.15M$5.74B$9.51B
Dividend YieldN/AN/A4.60%3.99%
P/E Ratio-1.786.1628.1120.03
Price / Sales18.72139.16460.63103.88
Price / CashN/A18.4136.5559.01
Price / Book-26.677.338.655.90
Net Income-$10.95M-$25.32M$3.25B$258.66M
7 Day PerformanceN/A1.11%4.20%2.23%
1 Month Performance1.30%3.73%10.83%12.77%
1 Year Performance23.13%54.07%34.67%19.36%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.80
flat
N/A+29.1%$19.58M$1.05M-1.7820
TELA
TELA Bio
2.9425 of 5 stars
$1.97
-0.5%
$7.25
+268.0%
-57.4%$77.93M$69.30M-1.40120
HYPR
Hyperfine
1.4355 of 5 stars
$0.99
+2.2%
$1.06
+7.1%
-0.9%$76.90M$12.89M-1.83190News Coverage
Positive News
NSPR
InspireMD
2.5395 of 5 stars
$2.50
-1.0%
$4.50
+80.4%
-14.4%$76.47M$7.03M-3.3350
CTCX
Carmell
N/A$3.63
-16.0%
N/A+316.0%$75.89M$32.84K0.0014
SRTS
Sensus Healthcare
1.1291 of 5 stars
$4.52
-1.8%
$11.67
+158.4%
-11.0%$74.33M$39.49M45.2040News Coverage
Positive News
ZYXI
Zynex
2.1784 of 5 stars
$2.45
+4.7%
$5.50
+124.5%
-74.9%$74.09M$192.35M-10.21770Upcoming Earnings
CTSO
Cytosorbents
1.6677 of 5 stars
$1.06
+1.9%
$5.50
+418.9%
-1.0%$66.37M$35.60M-3.79220Gap Up
RBOT
Vicarious Surgical
0.3751 of 5 stars
$10.76
+4.6%
$8.50
-21.0%
+77.7%$63.77MN/A-1.03210Gap Down
MDAI
Spectral AI
3.5112 of 5 stars
$2.44
-0.2%
$4.75
+95.1%
+51.4%$62.15M$29.96M-4.5583
SURG
SurgePays
3.1503 of 5 stars
$2.93
-1.0%
$9.00
+207.2%
-1.9%$59.82M$60.88M-1.0540

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners